Rapid Therapeutic Science Laboratories Inc. Stock Analysis RTSL
Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company is headquartered in De Leon, Texas and currently employs 3 full-time employees. The company went IPO on 2013-10-31. The firm is also focusing on manufacturing its own branded metered dose inhaler (MDI) under the inhaler brand name.
Read More Rapid Therapeutic Science Laboratories Inc (RTSL) Chart
Key Statistics of Rapid Therapeutic Science Laboratories Inc (RTSL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
109.00P/E Ratio (TTM)
-52 Week Range
Market Cap
110.00KAvg. Volume
109.00Dividend Yield
-Financial Metrics & Statements of Rapid Therapeutic Science Laboratories Inc (RTSL)
FAQ's for Rapid Therapeutic Science Laboratories Inc (RTSL)
- According to Musaffa’s Shariah screening methodology, Rapid Therapeutic Science Laboratories Inc (RTSL) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.